BI publishes female sexual disorder survey

10 November 2008

Germany's Boehringer Ingleheim has published results from the PRESIDE survey of more than 31,000 women, showing that hypoactive sexual desire disorder is the most commonly-reported sexual problem in adult women, in the journal Obstetrics & Gynecology.

In the cross-sectional, population-based, nationally-representative survey of 31,581 adult US women, 44.2% of them reported experiencing a sexual problem of some kind. Low desire was most common, reported in 38.7% of the respondents; low arousal (26.1%) and orgasm difficulty (20.5%) were less frequent. Of all the women surveyed, 22.8% said they had sexually-related personal distress. Low desire was the most common distressing sexual problem, affecting 10% of respondents. It was twice as common as distress associated with arousal (5.4%) or orgasm problems (4.7%).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight